arXiv:2506. 14488v2 Announce Type: replace-cross Abstract: Structure-based drug design (SBDD) models are central to modern pharmaceutical research, enabling the rational exploration of protein-ligand interactions at atomic resolution.
By Dong Xu, Zhangfan Yang, Junchuang Cai, Sisi Yuan, Zexuan Zhu, Jianqiang Li, Junkai Ji
The paper introduces a curriculum learning strategy for generative flexible docking, a task that predicts protein‑ligand complex configurations from an apo protein structure and a ligand SMILES string. By gradually incorporating examples with large conformational changes during training, the authors enhance an existing generative model, achieving a 46.52% top‑1 success rate on the PDBBind ESMFold apo benchmark and outperforming prior baselines. The approach leverages diffusion and flow‑based generative models to model the posterior distribution over ligand poses and protein conformations conditioned on the apo input.
By Wenyin Zhou, Hossein Azizpour
arXiv:2512. 02328v2 Announce Type: replace-cross Abstract: Selecting an effective docking algorithm is highly context-dependent, and no single method performs reliably across structural, chemical, and protocol regimes.
By Jiabao Brad Wang, Siyuan Cao, Hongxuan Wu, Yiliang Yuan, Mustafa Misir
arXiv:2608.20366v1 Announce Type: cross
Abstract: Molecular docking requires reasoning jointly about ligand pose and protein flexibility. Most diffusion-based docking models predict torsional updates...
By Maksim Zhdanov, Pavel Strashnov, Vladislav Kurenkov
FuseDiff is an end‑to‑end diffusion model designed for dual‑target structure‑based drug design, jointly generating a ligand graph and two pocket‑specific binding poses conditioned on both target pockets. It employs a message‑passing backbone with Dual‑target Local Context Fusion (DLCF) to fuse ligand atom contexts from both pockets, preserving symmetry while enabling expressive joint modeling. The model enforces topological consistency across the two poses and allows target‑specific geometric adaptation, achieving state‑of‑the‑art docking performance and enabling systematic assessment of dual‑target pose quality before docking‑based pose search.
By Jianliang Wu, Anjie Qiao, Zhen Wang, Zhewei Wei, Sheng Chen
arXiv:2606. 06717v1 Announce Type: cross Abstract: While generative AI models have demonstrated remarkable success in structure-based drug design, they predominantly rely on deep binding pockets and struggle to sample effective ligands for challenging low-pocketability targets, such as the historically "undruggable" oncology targets KRAS and MYC.
By Saket Reddy, Shiwei Liu